Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
about
Virotherapy: cancer gene therapy at last?Analysis of Hypericin-Mediated Effects and Implications for Targeted Photodynamic Therapy.Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines.Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity.Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice.Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response.Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.Cellular vaccination of MLH1-/- mice - an immunotherapeutic proof of concept study.Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability.
P2860
Q28066228-7DFB1909-920C-4815-B178-C7A7AA95CC74Q38665155-CDEB6D9F-D661-439B-933A-FC1C70B99650Q38756454-E827B84D-348E-4BC8-A09F-3AFC769BCB43Q39037485-6CC9EC38-CBF9-42D9-8D08-194823724868Q46064523-76196D12-9E42-45E1-B1B8-4850A012101DQ47361686-6CA1EB3D-D650-4323-BA94-631118FE76B5Q47737905-A1A61984-BDFC-40C1-AF78-0F64006BCE8DQ49835172-D83DA184-B1C7-4486-AEDE-BA5EFBCB5056Q50423289-058F02C4-D2BD-42C0-9447-28533CD180A9Q50535283-72005168-593B-46A1-984E-A20B32612C61Q52746279-55025516-6806-4302-BE95-206115B4ECBFQ55174561-603E1439-27A4-4CF2-BAD2-F3FD988EDB13Q55396596-74A535AE-600A-4D25-AAD6-42741458199C
P2860
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@ast
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@en
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@nl
type
label
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@ast
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@en
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@nl
prefLabel
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@ast
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@en
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@nl
P2093
P2860
P3181
P356
P1476
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
@en
P2093
Jochen Belmans
Lien Vandenberk
Matthias Van Woensel
Stefaan W Van Gool
P2860
P3181
P356
10.3389/FIMMU.2015.00663
P407
P50
P577
2015-01-01T00:00:00Z